Roche Holding AG’s experimental lung cancer pill outperformed two approved medicines in a late-stage study, boosting the ...
Experimental drug, divarasib, showed meaningful improvements in both patients’ overall survival and the time they survived ...
The Phase 3 trial compared Roche’s divarasib with treatments sold by Amgen and Bristol Myers in patients with non-small cell ...
According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle ...
Risk-based strategies are superior to the U.S. Preventive Services Task Force (USPSTF) criteria for optimizing efficiency and ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Asbestos exposure stands as one of the most widespread, destructive and persistent occupational health disasters of the 20th century.
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed clinically meaningful improvements in ...
Pfizer Inc. said an experimental drug failed to improve survival in patients with an advanced form of lung cancer that couldn ...
It’s been a year since Australia launched its National Lung Cancer Screening Program. Since July 2025, about 100,000 ...
A new SIU-led program will expand lung cancer screenings and early detection efforts across central and southern Illinois.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results